Calendar HCW Biologics Inc.

Equities

HCWB

US40423R1059

Market Closed - Nasdaq 21:00:00 14/05/2024 BST 5-day change 1st Jan Change
1.15 USD +2.68% Intraday chart for HCW Biologics Inc. -10.16% -6.12%

Chart calendar HCW Biologics Inc.

0a76930b4a10e75809c9ca1272d3.O7ydJZYW-TDM9OeeJNNVm9oNpWebtVGPTrc8KdAdy1A.dIzSFq5uzki8wqTQHZ4w4o4_7Sv2wRa5BthbXbQljCp-jdVi-W6qX4qn1w~550f4dd8a0b6265826d828c3a2f4d258

Upcoming events on HCW Biologics Inc.

08/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
31/03/2025 Q4 2024 Earnings Release (Projected)

Past events on HCW Biologics Inc.

08/05/2024 Q1 2024 Earnings Release (Projected)
01/04/2024 21:10 Q4 2023 Earnings Release
14/11/2023 12:00 Q3 2023 Earnings Release
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Poster No - 767
11/09/2023 12:00 H.C. Wainwright Global Investment Conference - Pre recorded
11/08/2023 12:00 Q2 2023 Earnings Release
22/06/2023 15:00 Maxim Group Virtual Healthcare Conference
13/06/2023 15:00 Annual General Meeting
09/05/2023 12:15 Q1 2023 Earnings Release
18/04/2023 14:00 American Association for Cancer Research Meeting - Abstract No - 4441
28/03/2023 21:25 Q4 2022 Earnings Release
11/11/2022 14:00 Society for Immunotherapy of Cancer Meeting - Poster 724
07/11/2022 21:45 Q3 2022 Earnings Release
12/08/2022 12:00 Interim 2022 Earnings Release
15/06/2022 15:00 Annual General Meeting
13/05/2022 12:15 Q1 2022 Earnings Release
09/05/2022 22:30 American Association of Immunologists Immunology Meeting - Abstract Number : 2389
09/05/2022 17:08 American Association of Immunologists Immunology Meeting - Abstract Number : 2442
08/05/2022 22:30 American Association of Immunologists Immunology Meeting - Abstract Number : 2442
19/04/2022 21:00 CED Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,10


0,00
0,00
-
6,72
5,39
24.7%
2,84
1,52
87.21%

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-13,2
-13,5
1.92%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-13,4
-14,5
7.58%
-15,1
-14,7
-2.6%
-25,7
-20,4
-25.82%

-23,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-12,9
-13,9
7.22%
-14,9
-14,2
-5.21%
-25,0
-19,8
-26.2%

-23,9

Net income
Million USD
Released
Forecast
Spread
0,00


-12,9
-14,8
13.23%
-14,9
-14,7
-1.15%
-25,0
-19,8
-26.2%

-23,9

EPS
USD
Released
Forecast
Spread
-0,64


-0,69
-0,77
9.8%
-0,42
-0,42
-1.2%
-0,70
-0,55
-27.27%

-0,57

Announcement Date26/05/2129/03/2228/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
3,12
0,00
-
0,45
0,00
-
1,81
0,00
-
1,34
0,00
-
0,04
0,00
-
0,62
0,00
-
0,85
0,00
-
1,32
0,00
-
EBITDA
Million USD
Released
Forecast
Spread









-3,55
-4,50
21.04%
-5,12
-5,40
5.19%
-4,80
-5,20
7.64%
-4,23
-5,30
20.26%






EBIT
Million USD
Released
Forecast
Spread
-3,11
-4,19
25.66%
-1,88
-5,00
62.38%
-3,51
-4,58
23.39%
-4,02
-4,60
12.64%
-5,67
-5,29
-7.12%



-4,51
-5,17
12.82%
-5,08
-4,65
-9.13%
-10,8
-5,49
-96.11%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,17
-4,17
23.97%



-2,75
-4,07
32.36%
-3,91
-4,30
9.04%
-5,42
-4,68
-15.76%



-4,30
-5,17
16.81%
-4,94
-4,65
-6.14%
-10,7
-5,49
-94.51%
Net income
Million USD
Released
Forecast
Spread
-3,17
-4,17
23.97%



-3,51
-4,58
23.4%
-3,91
-4,60
14.94%
-5,42
-5,24
-3.4%
-5,07
-5,70
11.04%
-4,30
-5,17
16.81%
-4,94
-4,65
-6.14%
-10,7
-5,49
-94.51%
EPS
USD
Released
Forecast
Spread
-0,09
-0,12
25%
-0,06
-0,11
45.45%
-0,10
-0,13
20%
-0,11
-0,13
15.38%
-0,15
-0,15
-3.45%
-0,14
-0,16
12.5%
-0,12
-0,16
22.58%
-0,14
-0,13
-7.69%
-0,30
-0,15
-100%
Announcement Date29/03/2213/05/2212/08/2207/11/2228/03/2309/05/2311/08/2314/11/2301/04/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HCWB Stock
  4. Calendar HCW Biologics Inc.